Post-translational regulation and modifications of flavivirus structural proteins
Flaviviruses are a group of single-stranded, positive-sense RNA viruses that generally circulate between arthropod vectors and susceptible vertebrate hosts, producing significant human and veterinary disease burdens. Intensive research efforts have broadened our scientific understanding of the repli...
Saved in:
Published in | Journal of general virology Vol. 96; no. Pt 7; pp. 1551 - 1569 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.07.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Flaviviruses are a group of single-stranded, positive-sense RNA viruses that generally circulate between arthropod vectors and susceptible vertebrate hosts, producing significant human and veterinary disease burdens. Intensive research efforts have broadened our scientific understanding of the replication cycles of these viruses and have revealed several elegant and tightly co-ordinated post-translational modifications that regulate the activity of viral proteins. The three structural proteins in particular - capsid (C), pre-membrane (prM) and envelope (E) - are subjected to strict regulatory modifications as they progress from translation through virus particle assembly and egress. The timing of proteolytic cleavage events at the C-prM junction directly influences the degree of genomic RNA packaging into nascent virions. Proteolytic maturation of prM by host furin during Golgi transit facilitates rearrangement of the E proteins at the virion surface, exposing the fusion loop and thus increasing particle infectivity. Specific interactions between the prM and E proteins are also important for particle assembly, as prM acts as a chaperone, facilitating correct conformational folding of E. It is only once prM/E heterodimers form that these proteins can be secreted efficiently. The addition of branched glycans to the prM and E proteins during virion transit also plays a key role in modulating the rate of secretion, pH sensitivity and infectivity of flavivirus particles. The insights gained from research into post-translational regulation of structural proteins are beginning to be applied in the rational design of improved flavivirus vaccine candidates and make attractive targets for the development of novel therapeutics. |
---|---|
AbstractList | Flaviviruses are a group of single-stranded, positive-sense RNA viruses that generally circulate between arthropod vectors and susceptible vertebrate hosts, producing significant human and veterinary disease burdens. Intensive research efforts have broadened our scientific understanding of the replication cycles of these viruses and have revealed several elegant and tightly co-ordinated post-translational modifications that regulate the activity of viral proteins. The three structural proteins in particular - capsid (C), pre-membrane (prM) and envelope (E) - are subjected to strict regulatory modifications as they progress from translation through virus particle assembly and egress. The timing of proteolytic cleavage events at the C-prM junction directly influences the degree of genomic RNA packaging into nascent virions. Proteolytic maturation of prM by host furin during Golgi transit facilitates rearrangement of the E proteins at the virion surface, exposing the fusion loop and thus increasing particle infectivity. Specific interactions between the prM and E proteins are also important for particle assembly, as prM acts as a chaperone, facilitating correct conformational folding of E. It is only once prM/E heterodimers form that these proteins can be secreted efficiently. The addition of branched glycans to the prM and E proteins during virion transit also plays a key role in modulating the rate of secretion, pH sensitivity and infectivity of flavivirus particles. The insights gained from research into post-translational regulation of structural proteins are beginning to be applied in the rational design of improved flavivirus vaccine candidates and make attractive targets for the development of novel therapeutics. |
Author | Roby, Justin A Hall, Roy A Setoh, Yin Xiang Khromykh, Alexander A |
Author_xml | – sequence: 1 givenname: Justin A surname: Roby fullname: Roby, Justin A organization: 1Australian Infectious Diseases Research Centre, The University of Queensland, Australia 2School of Chemistry and Molecular Biosciences, The University of Queensland, Australia – sequence: 2 givenname: Yin Xiang surname: Setoh fullname: Setoh, Yin Xiang organization: 1Australian Infectious Diseases Research Centre, The University of Queensland, Australia 2School of Chemistry and Molecular Biosciences, The University of Queensland, Australia – sequence: 3 givenname: Roy A surname: Hall fullname: Hall, Roy A organization: 1Australian Infectious Diseases Research Centre, The University of Queensland, Australia 2School of Chemistry and Molecular Biosciences, The University of Queensland, Australia – sequence: 4 givenname: Alexander A surname: Khromykh fullname: Khromykh, Alexander A organization: 1Australian Infectious Diseases Research Centre, The University of Queensland, Australia 2School of Chemistry and Molecular Biosciences, The University of Queensland, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25711963$$D View this record in MEDLINE/PubMed |
BookMark | eNo9UMtKxDAUDTLiPHTnWrp0YWseTTtZyuALBlTQdchTIm0zJumAf2-0o3dzX-eewz1LMBv8YAA4R7BCkLHrvQsVrGAO1h6BBaobWuK8mIEFhBiXiKB2DpYxfkCI6pq2J2COaYsQa8gCvDz7mMoUxBA7kZwfRFcE8z5OTSEGXfReO-vU7yAW3ha2E3uXZcdYxBRGlcaQr3bBJ-OGeAqOreiiOTvkFXi7u33dPJTbp_vHzc22VITRVGJsJGooVpa0tEZYr62uscHIyjoXhFoqrWasaSjEsiVQYUOloUTjWjKNyQpcTrxZ-HM0MfHeRWW6TgzGj5GjFq7XjBLCMvRqgqrgYwzG8l1wvQhfHEH-YyLP33DIJxMz_OLAPMre6H_wn2vkG_ldcHw |
CitedBy_id | crossref_primary_10_3390_v10040193 crossref_primary_10_1371_journal_pntd_0007299 crossref_primary_10_3390_vaccines9090946 crossref_primary_10_1016_j_virol_2016_01_001 crossref_primary_10_1038_s44298_024_00031_7 crossref_primary_10_3390_v10090453 crossref_primary_10_3390_v10100541 crossref_primary_10_3390_v9110338 crossref_primary_10_1016_j_antiviral_2022_105511 crossref_primary_10_1007_s00705_022_05697_z crossref_primary_10_3390_v14071501 crossref_primary_10_3389_fmicb_2019_01465 crossref_primary_10_4137_BCI_S30379 crossref_primary_10_3390_ijms20051101 crossref_primary_10_3390_v11010068 crossref_primary_10_1186_s13567_021_00966_2 crossref_primary_10_3390_membranes11050335 crossref_primary_10_1016_j_virusres_2020_198065 crossref_primary_10_1038_s41598_024_63407_y crossref_primary_10_1016_j_phymed_2023_154976 crossref_primary_10_1016_j_virol_2020_09_001 crossref_primary_10_1128_JVI_00447_16 crossref_primary_10_3389_fnmol_2018_00116 crossref_primary_10_3390_v9110326 crossref_primary_10_1016_j_celrep_2019_08_005 crossref_primary_10_1099_jgv_0_001991 crossref_primary_10_1038_s41598_017_16475_2 crossref_primary_10_1074_mcp_R116_065649 crossref_primary_10_1128_JVI_01455_17 crossref_primary_10_1016_j_celrep_2017_03_071 crossref_primary_10_1038_srep44642 crossref_primary_10_1152_ajpcell_00028_2022 crossref_primary_10_1007_s00018_018_2968_8 crossref_primary_10_1016_j_vetmic_2021_109262 crossref_primary_10_1128_JVI_00618_20 crossref_primary_10_1016_j_virol_2016_11_002 crossref_primary_10_1038_s41541_018_0072_6 crossref_primary_10_1007_s00253_021_11364_1 crossref_primary_10_1016_j_tibs_2020_12_007 crossref_primary_10_1007_s00705_022_05632_2 crossref_primary_10_3390_vaccines12020215 crossref_primary_10_3390_v12101116 crossref_primary_10_1007_s12035_017_0635_y crossref_primary_10_1016_j_antiviral_2020_104884 crossref_primary_10_1128_JVI_00573_21 crossref_primary_10_3390_v14081808 crossref_primary_10_1128_mra_00841_23 crossref_primary_10_3390_v10080422 crossref_primary_10_1128_JVI_00104_20 crossref_primary_10_1016_j_virusres_2016_11_029 crossref_primary_10_1080_09712119_2022_2026361 crossref_primary_10_1016_j_plipres_2016_09_005 crossref_primary_10_1016_j_antiviral_2019_04_003 crossref_primary_10_1186_s12985_023_02172_2 crossref_primary_10_1080_21645515_2020_1826798 crossref_primary_10_1111_1348_0421_12458 crossref_primary_10_1371_journal_pntd_0005019 crossref_primary_10_3390_v13081479 crossref_primary_10_1016_j_curtheres_2017_10_003 crossref_primary_10_1128_JVI_00694_16 crossref_primary_10_1099_jgv_0_001927 crossref_primary_10_1080_07391102_2020_1862707 crossref_primary_10_3390_v13112293 crossref_primary_10_3389_fmicb_2017_00110 crossref_primary_10_1016_j_isci_2019_02_012 crossref_primary_10_1099_jgv_0_001647 crossref_primary_10_1016_j_antiviral_2022_105423 crossref_primary_10_3390_vaccines8020170 crossref_primary_10_1038_s41598_021_02929_1 crossref_primary_10_1021_acs_chemrev_7b00719 |
Cites_doi | 10.1126/science.1153264 10.1371/journal.pntd.0000311 10.1038/sj.embor.embor866 10.1128/JVI.77.7.4370-4382.2003 10.1099/vir.0.034793-0 10.1016/j.virol.2012.07.011 10.1111/j.1462-5822.2004.00480.x 10.1128/JVI.77.12.7143-7149.2003 10.1128/JVI.75.22.10787-10799.2001 10.1007/978-3-0346-0277-8_13 10.1093/nar/gkm1051 10.1007/s00705-009-0350-8 10.4149/av_2013_01_27 10.1016/j.virol.2009.01.038 10.1099/vir.0.044453-0 10.1002/jmv.20205 10.1128/JVI.72.7.5967-5977.1998 10.1074/jbc.M605429200 10.1099/vir.0.007872-0 10.1186/1743-422X-8-138 10.1128/JVI.76.11.5480-5491.2002 10.1126/science.1185181 10.1073/pnas.0832193100 10.1016/0042-6822(85)90129-1 10.1016/0042-6822(88)90161-4 10.1016/j.antiviral.2012.10.007 10.1099/vir.0.81252-0 10.1038/nsmb.2463 10.1128/JVI.01735-06 10.3390/ijerph10127144 10.1038/nrmicro1067 10.1016/j.jsb.2013.04.005 10.1007/s00705-013-1688-5 10.1128/JVI.79.18.11813-11823.2005 10.1016/j.vaccine.2014.03.091 10.1016/j.cell.2005.11.042 10.1371/journal.pone.0008325 10.1073/pnas.051631398 10.1128/JVI.00037-07 10.1038/nrmicro1928 10.1126/science.1153263 10.1099/vir.0.81320-0 10.1128/JVI.02120-06 10.1016/j.chom.2009.03.007 10.1016/j.virol.2007.05.007 10.1186/1423-0127-17-39 10.1128/JVI.01552-13 10.1099/vir.0.012120-0 10.1099/vir.0.064121-0 10.1371/journal.ppat.1000632 10.1128/JVI.00116-07 10.1016/j.virusres.2008.02.008 10.1016/j.jsb.2013.11.001 10.1016/j.virol.2011.02.022 10.1128/JVI.71.11.8475-8481.1997 10.1084/jem.20021840 10.4269/ajtmh.1980.29.948 10.1128/JVI.77.21.11357-11366.2003 10.1016/S0042-6822(03)00536-1 10.1016/j.vaccine.2010.07.055 10.1099/vir.0.80247-0 10.1128/JVI.74.1.24-32.2000 10.1371/journal.ppat.1000718 10.1016/j.tim.2011.02.002 10.1073/pnas.0305892101 10.1128/JVI.68.6.3794-3802.1994 10.1128/JVI.01025-09 10.1099/vir.0.036525-0 10.1006/viro.1996.0406 10.1128/JVI.00937-14 10.1182/blood-2012-05-430090 10.1038/nature07013 10.1016/j.micinf.2010.04.005 10.1007/BF01718326 10.1128/JVI.00789-08 10.1128/JVI.01900-09 10.1016/j.micinf.2010.10.014 10.1128/JVI.00696-10 10.1093/infdis/jir173 10.1038/nm1144 10.1007/s00705-004-0463-z 10.1099/vir.0.80283-0 10.1016/j.jsb.2006.09.002 10.1128/JVI.00940-14 10.1074/jbc.M114.610428 10.1128/JVI.67.3.1672-1675.1993 10.1073/pnas.90.13.6218 10.4269/ajtmh.2010.09-0262 10.1016/S0092-8674(02)00660-8 10.1371/journal.pntd.0000934 10.1016/j.vaccine.2013.08.027 10.1016/0042-6822(92)90745-B 10.1099/vir.0.18723-0 10.1016/j.str.2004.04.024 10.1089/vim.2004.17.461 10.1099/vir.0.81236-0 10.1637/9743-032811-Reg.1 10.1016/j.virol.2011.01.003 10.1016/0042-6822(87)90460-0 10.4269/ajtmh.2011.10-0439 10.1099/0022-1317-73-11-2999 10.1128/JVI.06072-11 10.1128/JVI.78.1.178-186.2004 10.1099/vir.0.015339-0 10.1128/JVI.76.7.3534-3543.2002 10.1016/j.bbrc.2005.01.121 10.1128/JVI.00118-14 10.1128/JVI.79.21.13262-13274.2005 10.1093/emboj/cdg270 10.1128/JVI.78.5.2367-2381.2004 10.1186/1471-2180-13-194 10.1042/BJ20112219 10.1016/j.cell.2010.07.038 10.1016/j.chom.2009.04.001 10.1128/JVI.01637-09 10.1128/JVI.69.9.5816-5820.1995 10.1016/j.str.2004.06.019 10.1006/viro.1997.8629 10.1016/S0042-6822(95)80018-2 10.1006/viro.1997.8608 10.1371/journal.ppat.1002655 10.1074/jbc.M111.226142 10.1128/JVI.01125-06 10.1016/j.virol.2010.11.006 10.1111/j.1462-5822.2011.01649.x 10.1128/JVI.77.1.443-451.2003 10.1128/JVI.79.6.3448-3458.2005 10.1111/j.1749-6632.2001.tb02719.x 10.1099/vir.0.055269-0 10.1128/JVI.79.13.8339-8347.2005 10.1016/j.antiviral.2011.10.017 10.1038/375291a0 10.1074/jbc.M112.384446 10.1006/viro.1993.1252 10.1099/vir.0.035964-0 10.1128/JVI.01180-08 10.1099/0022-1317-74-12-2653 10.1016/j.chom.2010.07.007 10.1099/vir.0.015255-0 10.1128/JVI.78.15.8078-8084.2004 10.1038/embor.2011.75 10.1007/BF01309477 10.1099/vir.0.2008/003731-0 10.1006/viro.1993.1006 10.1128/JVI.02653-08 10.1074/jbc.M504337200 10.1128/JVI.73.10.8083-8094.1999 10.1128/JVI.80.3.1290-1301.2006 10.1016/j.virol.2010.02.008 10.1128/JVI.72.3.2141-2149.1998 10.1006/viro.1997.8570 10.3201/eid1402.070457 10.1016/j.vaccine.2004.11.068 10.1371/journal.pone.0024365 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1099/vir.0.000097 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1465-2099 |
EndPage | 1569 |
ExternalDocumentID | 10_1099_vir_0_000097 25711963 |
Genre | Journal Article Review |
GroupedDBID | --- -~X .55 .GJ 186 18M 2WC 39C 3O- 4.4 53G 5GY 5RE AAJMC ABDNZ ACBTR ACGFO ACPEE ACYGS ADBBV ADCDP ADCOW AEILP AENEX AFFNX AGCDD AI. AJKYU ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CGR CJ0 CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 K-O L7B NPM OHT OK1 P2P RGM TR2 VH1 W8F WH7 WHG WOQ X7M Y6R YKV YSK ZGI ~KM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c395t-22eb1652cf375412d8fd42e21fb4d4235f5bfd9966502b730c2e5be53d24b9d23 |
ISSN | 0022-1317 |
IngestDate | Fri Oct 25 22:42:02 EDT 2024 Thu Nov 21 22:03:54 EST 2024 Tue Oct 15 23:53:47 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Pt 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c395t-22eb1652cf375412d8fd42e21fb4d4235f5bfd9966502b730c2e5be53d24b9d23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://doi.org/10.1099/vir.0.000097 |
PMID | 25711963 |
PQID | 1708895339 |
PQPubID | 23479 |
PageCount | 19 |
ParticipantIDs | proquest_miscellaneous_1708895339 crossref_primary_10_1099_vir_0_000097 pubmed_primary_25711963 |
PublicationCentury | 2000 |
PublicationDate | 2015-Jul 2015-07-01 20150701 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-Jul |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of general virology |
PublicationTitleAlternate | J Gen Virol |
PublicationYear | 2015 |
References | r2 r3 r5 r8 r9 r90 r92 r100 r94 r93 r95 r10 r98 r97 r12 r11 r99 r14 r13 r16 r15 r18 r17 r19 Monath (r91) 1980; 29 Amberg (r6) 1999; 73 r21 r20 r23 r22 r25 r24 r27 r26 r29 r28 Roby (r117) 2012 r120 r121 r122 r30 Gubler (r37) 2012 r32 r116 r31 r34 r118 r33 r119 r36 r112 r35 r113 r38 r114 r115 r39 Amberg (r7) 1994; 68 r110 r111 r41 r40 r43 r105 r42 r106 r45 r107 r44 r108 r47 r101 r46 r102 r49 r103 r48 r109 r141 r142 r143 r144 r50 Lindenbach (r70) 2007 r52 r51 r140 r138 r53 r139 r56 r55 r58 r134 r135 Khromykh (r54) 1998; 72 r136 r59 Muller (r96) 2012 r137 King (r57) 2012 r132 r133 r61 r63 r62 r65 r127 r64 r128 Stadler (r130) 1997; 71 r67 r129 r66 r69 r123 r68 r124 r125 r126 Stocks (r131) 1998; 72 r72 r71 r160 r74 r73 r76 r75 r78 r77 Allison (r4) 1995; 69 r156 r79 r157 r158 r159 Konishi (r60) 1993; 67 r152 r153 r81 r154 r80 r155 r83 r82 r85 r150 r84 r151 r87 r149 r86 r89 r88 r145 r146 r147 r148 Olson (r104) 2012 r1 |
References_xml | – ident: r150 doi: 10.1126/science.1153264 – ident: r63 doi: 10.1371/journal.pntd.0000311 – ident: r100 doi: 10.1038/sj.embor.embor866 – ident: r76 doi: 10.1128/JVI.77.7.4370-4382.2003 – start-page: 297 volume-title: Molecular Virology and Control of Flaviviruses year: 2012 ident: r104 article-title: Flavivirus–vector interactions contributor: fullname: Olson – ident: r113 doi: 10.1099/vir.0.034793-0 – ident: r17 doi: 10.1016/j.virol.2012.07.011 – ident: r61 doi: 10.1111/j.1462-5822.2004.00480.x – ident: r45 doi: 10.1128/JVI.77.12.7143-7149.2003 – ident: r81 doi: 10.1128/JVI.75.22.10787-10799.2001 – ident: r116 doi: 10.1007/978-3-0346-0277-8_13 – ident: r44 doi: 10.1093/nar/gkm1051 – ident: r74 doi: 10.1007/s00705-009-0350-8 – ident: r152 doi: 10.4149/av_2013_01_27 – ident: r94 doi: 10.1016/j.virol.2009.01.038 – ident: r126 doi: 10.1099/vir.0.044453-0 – ident: r127 doi: 10.1002/jmv.20205 – volume: 72 start-page: 5967 year: 1998 ident: r54 article-title: Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans publication-title: J Virol doi: 10.1128/JVI.72.7.5967-5977.1998 contributor: fullname: Khromykh – ident: r26 doi: 10.1074/jbc.M605429200 – ident: r132 doi: 10.1099/vir.0.007872-0 – ident: r157 doi: 10.1186/1743-422X-8-138 – ident: r75 doi: 10.1128/JVI.76.11.5480-5491.2002 – ident: r28 doi: 10.1126/science.1185181 – ident: r89 doi: 10.1073/pnas.0832193100 – ident: r143 doi: 10.1016/0042-6822(85)90129-1 – ident: r84 doi: 10.1016/0042-6822(88)90161-4 – ident: r3 doi: 10.1016/j.antiviral.2012.10.007 – ident: r88 doi: 10.1099/vir.0.81252-0 – ident: r160 doi: 10.1038/nsmb.2463 – volume-title: Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses year: 2012 ident: r57 contributor: fullname: King – ident: r49 doi: 10.1128/JVI.01735-06 – ident: r50 doi: 10.3390/ijerph10127144 – ident: r95 doi: 10.1038/nrmicro1067 – ident: r159 doi: 10.1016/j.jsb.2013.04.005 – ident: r2 doi: 10.1007/s00705-013-1688-5 – ident: r31 doi: 10.1128/JVI.79.18.11813-11823.2005 – ident: r105 doi: 10.1016/j.vaccine.2014.03.091 – ident: r111 doi: 10.1016/j.cell.2005.11.042 – ident: r139 doi: 10.1371/journal.pone.0008325 – start-page: 1 volume-title: Molecular Virology and Control of Flaviviruses year: 2012 ident: r37 article-title: Flaviviruses: past, present and future contributor: fullname: Gubler – ident: r110 doi: 10.1073/pnas.051631398 – ident: r155 doi: 10.1128/JVI.00037-07 – ident: r98 doi: 10.1038/nrmicro1928 – ident: r68 doi: 10.1126/science.1153263 – ident: r67 doi: 10.1099/vir.0.81320-0 – ident: r106 doi: 10.1128/JVI.02120-06 – ident: r142 doi: 10.1016/j.chom.2009.03.007 – ident: r15 doi: 10.1016/j.virol.2007.05.007 – ident: r69 doi: 10.1186/1423-0127-17-39 – ident: r118 doi: 10.1128/JVI.01552-13 – ident: r39 doi: 10.1099/vir.0.012120-0 – ident: r119 doi: 10.1099/vir.0.064121-0 – ident: r122 doi: 10.1371/journal.ppat.1000632 – ident: r92 doi: 10.1128/JVI.00116-07 – ident: r86 doi: 10.1016/j.virusres.2008.02.008 – ident: r109 doi: 10.1016/j.jsb.2013.11.001 – ident: r129 doi: 10.1016/j.virol.2011.02.022 – volume: 71 start-page: 8475 year: 1997 ident: r130 article-title: Proteolytic activation of tick-borne encephalitis virus by furin publication-title: J Virol doi: 10.1128/JVI.71.11.8475-8481.1997 contributor: fullname: Stadler – ident: r133 doi: 10.1084/jem.20021840 – volume: 29 start-page: 948 year: 1980 ident: r91 article-title: Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1980.29.948 contributor: fullname: Monath – ident: r5 doi: 10.1128/JVI.77.21.11357-11366.2003 – ident: r18 doi: 10.1016/S0042-6822(03)00536-1 – ident: r103 doi: 10.1016/j.vaccine.2010.07.055 – ident: r128 doi: 10.1099/vir.0.80247-0 – ident: r65 doi: 10.1128/JVI.74.1.24-32.2000 – ident: r120 doi: 10.1371/journal.ppat.1000718 – ident: r121 doi: 10.1016/j.tim.2011.02.002 – ident: r80 doi: 10.1073/pnas.0305892101 – volume: 68 start-page: 3794 year: 1994 ident: r7 article-title: NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies publication-title: J Virol doi: 10.1128/JVI.68.6.3794-3802.1994 contributor: fullname: Amberg – ident: r125 doi: 10.1128/JVI.01025-09 – ident: r25 doi: 10.1099/vir.0.036525-0 – ident: r99 doi: 10.1006/viro.1996.0406 – ident: r107 doi: 10.1128/JVI.00937-14 – ident: r146 doi: 10.1182/blood-2012-05-430090 – ident: r19 doi: 10.1038/nature07013 – ident: r12 doi: 10.1016/j.micinf.2010.04.005 – ident: r53 doi: 10.1007/BF01718326 – ident: r56 doi: 10.1128/JVI.00789-08 – ident: r66 doi: 10.1128/JVI.01900-09 – ident: r22 doi: 10.1016/j.micinf.2010.10.014 – ident: r47 doi: 10.1128/JVI.00696-10 – ident: r29 doi: 10.1093/infdis/jir173 – ident: r82 doi: 10.1038/nm1144 – ident: r136 doi: 10.1007/s00705-004-0463-z – ident: r114 doi: 10.1099/vir.0.80283-0 – ident: r156 doi: 10.1016/j.jsb.2006.09.002 – ident: r134 doi: 10.1128/JVI.00940-14 – ident: r43 doi: 10.1074/jbc.M114.610428 – volume: 67 start-page: 1672 year: 1993 ident: r60 article-title: Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein publication-title: J Virol doi: 10.1128/JVI.67.3.1672-1675.1993 contributor: fullname: Konishi – ident: r71 doi: 10.1073/pnas.90.13.6218 – ident: r97 doi: 10.4269/ajtmh.2010.09-0262 – ident: r62 doi: 10.1016/S0092-8674(02)00660-8 – start-page: 1101 volume-title: Fields Virology year: 2007 ident: r70 article-title: Flaviviridae: the viruses and their replication contributor: fullname: Lindenbach – ident: r140 doi: 10.1371/journal.pntd.0000934 – ident: r52 doi: 10.1016/j.vaccine.2013.08.027 – ident: r112 doi: 10.1016/0042-6822(92)90745-B – ident: r32 doi: 10.1099/vir.0.18723-0 – ident: r30 doi: 10.1016/j.str.2004.04.024 – ident: r83 doi: 10.1089/vim.2004.17.461 – ident: r137 doi: 10.1099/vir.0.81236-0 – ident: r135 doi: 10.1637/9743-032811-Reg.1 – ident: r35 doi: 10.1016/j.virol.2011.01.003 – ident: r145 doi: 10.1016/0042-6822(87)90460-0 – ident: r14 doi: 10.4269/ajtmh.2011.10-0439 – ident: r16 doi: 10.1099/0022-1317-73-11-2999 – ident: r78 doi: 10.1128/JVI.06072-11 – start-page: 51 volume-title: Molecular Virology and Control of Flaviviruses year: 2012 ident: r96 article-title: ). The many faces of the flavivirus non-structural glycoprotein NS1 contributor: fullname: Muller – ident: r72 doi: 10.1128/JVI.78.1.178-186.2004 – ident: r23 doi: 10.1099/vir.0.015339-0 – ident: r58 doi: 10.1128/JVI.76.7.3534-3543.2002 – ident: r11 doi: 10.1016/j.bbrc.2005.01.121 – ident: r48 doi: 10.1128/JVI.00118-14 – ident: r40 doi: 10.1128/JVI.79.21.13262-13274.2005 – ident: r153 doi: 10.1093/emboj/cdg270 – ident: r51 doi: 10.1128/JVI.78.5.2367-2381.2004 – ident: r79 doi: 10.1186/1471-2180-13-194 – ident: r87 doi: 10.1042/BJ20112219 – ident: r21 doi: 10.1016/j.cell.2010.07.038 – ident: r33 doi: 10.1016/j.chom.2009.04.001 – ident: r151 doi: 10.1128/JVI.01637-09 – volume: 69 start-page: 5816 year: 1995 ident: r4 article-title: Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form publication-title: J Virol doi: 10.1128/JVI.69.9.5816-5820.1995 contributor: fullname: Allison – ident: r154 doi: 10.1016/j.str.2004.06.019 – ident: r144 doi: 10.1006/viro.1997.8629 – ident: r1 doi: 10.1016/S0042-6822(95)80018-2 – ident: r85 doi: 10.1006/viro.1997.8608 – ident: r20 doi: 10.1371/journal.ppat.1002655 – ident: r141 doi: 10.1074/jbc.M111.226142 – ident: r102 doi: 10.1128/JVI.01125-06 – ident: r42 doi: 10.1016/j.virol.2010.11.006 – ident: r8 doi: 10.1111/j.1462-5822.2011.01649.x – ident: r59 doi: 10.1128/JVI.77.1.443-451.2003 – ident: r93 doi: 10.1128/JVI.79.6.3448-3458.2005 – ident: r123 doi: 10.1111/j.1749-6632.2001.tb02719.x – ident: r149 doi: 10.1099/vir.0.055269-0 – ident: r10 doi: 10.1128/JVI.79.13.8339-8347.2005 – ident: r9 doi: 10.1016/j.antiviral.2011.10.017 – ident: r115 doi: 10.1038/375291a0 – ident: r158 doi: 10.1074/jbc.M112.384446 – ident: r38 doi: 10.1006/viro.1993.1252 – ident: r148 doi: 10.1099/vir.0.035964-0 – ident: r46 doi: 10.1128/JVI.01180-08 – ident: r138 doi: 10.1099/0022-1317-74-12-2653 – ident: r34 doi: 10.1016/j.chom.2010.07.007 – ident: r90 doi: 10.1099/vir.0.015255-0 – ident: r55 doi: 10.1128/JVI.78.15.8078-8084.2004 – ident: r108 doi: 10.1038/embor.2011.75 – ident: r101 doi: 10.1007/BF01309477 – ident: r41 doi: 10.1099/vir.0.2008/003731-0 – ident: r147 doi: 10.1006/viro.1993.1006 – ident: r124 doi: 10.1128/JVI.02653-08 – ident: r77 doi: 10.1074/jbc.M504337200 – volume: 73 start-page: 8083 year: 1999 ident: r6 article-title: Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing publication-title: J Virol doi: 10.1128/JVI.73.10.8083-8094.1999 contributor: fullname: Amberg – ident: r27 doi: 10.1128/JVI.80.3.1290-1301.2006 – start-page: 21 volume-title: Molecular Virology and Control of Flaviviruses year: 2012 ident: r117 article-title: Flavivirus replication and assembly contributor: fullname: Roby – ident: r73 doi: 10.1016/j.virol.2010.02.008 – volume: 72 start-page: 2141 year: 1998 ident: r131 article-title: Signal peptidase cleavage at the flavivirus C–prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM publication-title: J Virol doi: 10.1128/JVI.72.3.2141-2149.1998 contributor: fullname: Stocks – ident: r64 doi: 10.1006/viro.1997.8570 – ident: r13 doi: 10.3201/eid1402.070457 – ident: r36 doi: 10.1016/j.vaccine.2004.11.068 – ident: r24 doi: 10.1371/journal.pone.0024365 |
SSID | ssj0014457 |
Score | 2.4968219 |
SecondaryResourceType | review_article |
Snippet | Flaviviruses are a group of single-stranded, positive-sense RNA viruses that generally circulate between arthropod vectors and susceptible vertebrate hosts,... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1551 |
SubjectTerms | Capsid Proteins - metabolism Flavivirus - physiology Gene Expression Regulation, Viral Glycosylation Host-Pathogen Interactions Humans Protein Multimerization Protein Processing, Post-Translational Proteolysis Viral Envelope Proteins - metabolism Virus Assembly Virus Release |
Title | Post-translational regulation and modifications of flavivirus structural proteins |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25711963 https://search.proquest.com/docview/1708895339 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELaAaRIvCAaMwpg8CZ6qQO3ESfM4TQM0tGn8krqnKE5sqKAJKgGp_PXc2UncCpAGL1Fkt07r73S-u3x3R8hOrPpcRSL3wDiOwEHxc6_fl6HHopT7fsolizA5-fef8Ogi-DUQA0e3NdklldzLHl_MK3kPqjAGuGKW7BuQbReFAbgHfOEKCMP1vzDGTrtehafNTRPTG9ve8g3JeFTmyAVyfDd9kz4MH4bj-7uuLR1rym6Yag3DOnD33FS9tLWpu5gTNx2FPy1tXU7TEqxwYdEzVZUmXPMPRgcggJdO0dnXHKflxH38-GpcjibXVzMJN_V0HZBgoiWvwnlilWiAzLmebXzUaFnbt7aWpr9VN5rSmmi2vajOYQ3AAP7cXs8UmrRU3ilkb0cGWtA7DFWJO9RaqmEzNU8-YK1EbK9wOGhZQOBOiqjOh4CH7U8_CutE11-eNVpe8USMRXK-TJZqfOh3KxcrZE4Vn8hH21x0skpOnksHddJBYZPpjHTQUlMnHdRJB22kY41cHPw8_3Hk1Q00vMyPReVxDidxKHimsdEx43lf5wFXnGkZwI0vtJA6R49X9LgEXZ9xJaQSfs4DGefcXycLRVmoDUJZJpXMwOBTLA40-NBpGqaK6Zhr4fM07JDdZoeSW1snJbH8hjiBn51gEVrc1A751mxfAooM306lhSrv7xIWIeMOvI-4Qz7bfW1XanDYfHVmiyw6WfxCFmCP1DaYi5X8agB_Amyrbj4 |
link.rule.ids | 314,780,784,27924,27925 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-translational+regulation+and+modifications+of+flavivirus+structural+proteins&rft.jtitle=Journal+of+general+virology&rft.au=Roby%2C+Justin+A&rft.au=Setoh%2C+Yin+Xiang&rft.au=Hall%2C+Roy+A&rft.au=Khromykh%2C+Alexander+A&rft.date=2015-07-01&rft.eissn=1465-2099&rft.volume=96&rft.issue=Pt+7&rft.spage=1551&rft_id=info:doi/10.1099%2Fvir.0.000097&rft_id=info%3Apmid%2F25711963&rft.externalDocID=25711963 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1317&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1317&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1317&client=summon |